| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Angelucci L |
Experiments with perfused frog's spinal cord |
Brit. J. Pharmacol. |
1956 |
| Brengelmann JC, Laverty S... |
Differential effects of lysergic acid and sodium amytal on immediate m... |
J. Ment. Sc. |
1958 |
| Brengelmann JC |
Effects of LSD-25 on tests of personality. |
J.Ment.Sci. |
1958 |
| Brengelmann JC, Pare CMB,... |
Alleviation of the psychological effects of LSD in man by 5-hydroxytry... |
J.Ment.Sc. |
1958 |
| D Silver, WG Anlyan, RW P... |
Serotonin Metabolism and the Dumping Syndrome |
Ann. Surg. |
1965 |
| CE Rackley, CE Mengel, M ... |
Vascular Complications with Use of Methysergide |
Arch. Int. Med. |
1966 |
| Browning LS |
Lysergic acid diethylamide: mutagenic effects in drosophila |
Science |
1968 |
| Budini R, Marinangeli A |
Interactions between some psychodrugs and flavins |
Z. Naturforsch. |
1970 |
| Emerit I, Roux C, Feingol... |
LSD: no chromosomal breakage in mother and embryos during rat pregnanc... |
Teratology |
1972 |
| Barfknecht CF, Nichols DE... |
Potential Psychotomimetics. 2-Amino-1,2,3,4-tetrahydronaphthalene Anal... |
J Med Chem |
1973 |
| Wingeleth DC, Makowski A,... |
Practical Experience with a Lysergic Acid Diethylamide (LSD) Radioimmu... |
Clin.Chem. |
1974 |
| Marquardt GM, DiStefano V... |
Pharmacological effects of (+/-)-, (S)-, and (R)-MDA |
Psychopharmacology o... |
1976 |
| Kovacic B, Wang-Lu LJ, Ru... |
Interactions of partial LSD analogs behavioral disrupting effects of L... |
European J. Pharmaco... |
1978 |
| Marquardt GM, DiStefano V... |
Pharmacological and Toxicological Effects of B-3,4-Methylenedioxyamphe... |
Toxicol.Appl.Pharmac... |
1978 |
| Siddik ZH, Barnes RD, Dri... |
The fate of lysergic acid di[14C]ethylamide ([14C]LSD) in the rat, gui... |
Biochemical Pharmaco... |
1979 |
| Siddik ZH, Barnes RD, Dri... |
The metabolism of lysergic acid diethylamide (LSD) in the isolated per... |
Biochem. Pharmacol. |
1979 |
| Müller-Schweinitzer E , E... |
Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induc... |
Naunyn-Schmiedeberg'... |
1983 |
| Engel G, v. Amsterdan F, ... |
125I-LSD, A New Useful Ligand For The Characterization And Localizatio... |
Naunyn-Schmiedeberg'... |
1983 |
| Engel G, Müller-Schweinit... |
Functional correlates to 5HT1 binding sites |
Proceedings of the 2... |
1984 |
| Engel G, Müuller-Schweini... |
5-HT Receptor Subtypes in Periphery and in CNS |
Blood Vessels: Form ... |
1984 |
| Richardson BP, Engel G, D... |
In Vitro Pharmacology of Neuronal 5-HT Receptor antagonists |
Proceedings of the 2... |
1984 |
| Engel G, Müller-Schweinit... |
2-[125Iodo]LSD, a new ligand for the characterisation and localisation... |
Naunyn-Schmiedeberg'... |
1984 |
| Engel G, Hoyer D, Kalkman... |
Identification of 5HT-2 Receptors on Longitudinal Muscle of the Guinea... |
J of Receptor Resear... |
1984 |
| Frith CH, Chang LW, Latti... |
Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the ra... |
Fundam Appl Toxicol |
1987 |
| Callaway CW, Wing LL, Gey... |
Serotonin release contributes to the locomotor stimulant effects of 3,... |
J Pharmacol Exp Ther |
1990 |
| Ali SF, Chang LW, Slikker... |
Biogenic amines as biomarkers for neurotoxicity |
Biomed Environ Sci |
1991 |
| Reis EC, Duggan AK, Adger... |
The impact of anti-drug advertising: Perceptions of middle and high sc... |
Arch Pediatr Adolesc... |
1994 |
| Winstock AR, King LA |
Ecstasy and neurodegeneration. Tablets often contain substances in add... |
BMJ |
1996 |
| Grob CS, Poland RE, Chang... |
Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans:... |
Behav Brain Res |
1996 |
| Sanguineti VR, Angelo A, ... |
GHB: A Home Brew |
Am J Drug Alcohol Ab... |
1997 |
| Bengel D, Murphy DL, Andr... |
Altered brain serotonin homeostasis and locomotor insensitivity to 3, ... |
Mol Pharmacol |
1998 |
| Chang L, Ernst T, Grob CS... |
Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymetha... |
J Magn Reson Imaging |
1999 |
| Chang L, Grob C, Ernst T,... |
Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebr... |
Psychiatry Research ... |
2000 |
| Kish SJ, Furukawa Y, Ang ... |
Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user |
Neurology |
2000 |
| Rashed AM, Anderson RA, K... |
Solid-phase extraction for profiling of ecstasy tablets |
J Forensic Sci |
2000 |
| Sangalli BC, Chiang W |
Toxicology of nutmeg abuse |
J Tox Clin Tox |
2000 |
| Ling LH, Marchant C, Buck... |
Poisoning with the recreational drug paramethoxyamphetamine ('death') |
Med J Aust |
2001 |
| Boyer EW, Quang L, Woolf ... |
Dextromethorphan and Ecstasy Pills |
JAMA |
2001 |
| Boyer EW, Kearney S, Shan... |
Poisoning from a dietary supplement administered during hospitalizatio... |
Pediatrics |
2002 |
| Cole JC, Bailey M, Sumnal... |
The content of ecstasy tablets: implications for the study of their lo... |
Addiction |
2002 |
| Cole JC, Bailey M, Sumnal... |
The content of ecstasy tablets: implications for the study of their lo... |
Addiction |
2002 |
| Zhou JF, Zhou YH, Zhang L... |
3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acety... |
Biomed Environ Sci |
2003 |
| Zhou JF, Chen P, Zhou YH,... |
3,4-Methylenedioxymethamphetamine (MDMA) abuse may cause oxidative str... |
Free Radic Res |
2003 |
| Engelsman EL |
Cannabis Control: the model of the WHO tobacco control treaty |
International Journa... |
2003 |
| Kim MK, Nightingale C, Ni... |
Influence of sex on the pharmacokinetic interaction of fleroxacin and ... |
Clin Pharmacokinet |
2003 |
| Back-Madruga C, Boone KB,... |
Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA ... |
Clin Neuropsychol |
2003 |
| Carmo H, Hengstler JG, de... |
Comparative metabolism of the designer drug 4-methylthioamphetamine by... |
Naunyn Schmiedebergs... |
2004 |
| Wang GJ, Volkow ND, Chang... |
Partial recovery of brain metabolism in methamphetamine abusers after ... |
Am J Psychiatry |
2004 |
| Kong LD, Cheng CH, Tan RX |
Inhibition of MAO A and B by some plant-derived alkaloids, phenols and... |
J Ethnopharmacol |
2004 |
| Carmo H, Hengstler JG, de... |
Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine 2C-B: analys... |
Toxicology |
2005 |
| Nutt D, King LA, Saulsbur... |
Development of a rational scale to assess the harm of drugs of potenti... |
Lancet |
2007 |
| Carliss RD, Radovsky A, C... |
Oral administration of dextromethorphan does not produce neuronal vacu... |
Neurotoxicology |
2007 |
| Tan WC, Lo C, Jong A, Xin... |
Marijuana and chronic obstructive lung disease: a population-based stu... |
CMAJ |
2009 |
| Hudson S, Ramsey J, King ... |
Use of high-resolution accurate mass spectrometry to detect reported a... |
J Anal Toxicol |
2010 |
| Carhart-Harris RL, King L... |
A web-based survey on mephedrone |
Drug Alcohol Depend |
2011 |
| Sainsbury PD, Kicman AT, ... |
Aminoindanes-the next wave of 'legal highs'? |
Drug Test Anal |
2011 |
| King LA, Kicman AT |
A brief history of 'new psychoactive substances' |
Drug Test Anal |
2011 |
| Wyman JF, Lavins ES, Enge... |
Postmortem Tissue Distribution of MDPV Following Lethal Intoxication b... |
J Anal Toxicol |
2013 |
| King LA |
New phenethylamines in Europe |
Drug Test Anal |
2014 |
| Kuypers KP, Ng L, Erritzo... |
Microdosing psychedelics: More questions than answers? An overview and... |
J Psychopharmacol |
2019 |
